These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1153656)

  • 1. Brain monoamines and Parkinsonism.
    Hornykiewicz O
    Psychopharmacol Bull; 1975 Jul; 11(3):34-5. PubMed ID: 1153656
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoamines and the regulation of wakefulness. I. Contribution and biochemical interpretation of the polygraphic data].
    Mouret JR; Renaud B; Quenin P; Michel D; Schott B
    Rev Neurol (Paris); 1972 Jul; 127(1):139-55. PubMed ID: 4358572
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic mechanisms in patients with extrapyramidal disease.
    Chase TN; Shoulson I
    Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical aspects of experimentally induced parkinsonism.
    Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
    [No Abstract]   [Full Text] [Related]  

  • 6. [L-dopa treatment in parkinsonism. Biochemical basis (author's transl)].
    Bieniowa A; Kolasa M; Reichowa J
    Przegl Lek; 1976; 33(4):463-7. PubMed ID: 1273343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemical aspects of human behaviour (author's transl)].
    Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856
    [No Abstract]   [Full Text] [Related]  

  • 8. Imbalance of brain monoamines and clinical disorders.
    Hornykiewicz O
    Prog Brain Res; 1982; 55():419-29. PubMed ID: 7163495
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parkinson disease].
    Lauschke HP; Thieme F
    Z Arztl Fortbild (Jena); 1981 Aug; 75(15):681-5. PubMed ID: 6125059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentration of biogenic amines in the central and peripheral nervous systems of rats with portacaval shunts, and their changes following administration of pargyline and levodopa].
    Alsasua A; Arias J; López-Sánchez ML; Estébanez E; Arias JI; García de Jalón PD; Durán Sacristán H
    Arch Farmacol Toxicol; 1982 Aug; 8(2):83-92. PubMed ID: 7159104
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 7-hydroxygluacine on brain biogenic monoamines].
    Petkov VD; Grakhoska T; Konstantinova E; Petkov VV
    Farmakol Toksikol; 1985; 48(3):19-22. PubMed ID: 4029374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-responsive parkinsonism associated with hydrocephalus.
    Kim MJ; Chung SJ; Sung YH; Lee MC; Im JH
    Mov Disord; 2006 Aug; 21(8):1279-81. PubMed ID: 16639728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [L-threo-DOPS therapy and parkinsonism].
    Narabayashi H
    No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in the contemporary treatment of parkinsonism.
    Eadie MJ
    Med J Aust; 1985 Jan; 142(2):113-7. PubMed ID: 2981393
    [No Abstract]   [Full Text] [Related]  

  • 15. The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease.
    Frey KA
    Ann Neurol; 2001 Mar; 49(3):285-7. PubMed ID: 11261500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
    Namba S; Ishimitsu H; Nakasone S
    No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
    [No Abstract]   [Full Text] [Related]  

  • 17. Tryptophan/nicotinic acid pathway during levodopa treatment of Parkinsonism.
    Cozzolino G; Campriani S; Campanelli C
    Acta Vitaminol Enzymol; 1975; 29(1-6):202-5. PubMed ID: 1244093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain monoamines and behavior.
    Seiden LS
    Psychopharmacol Bull; 1975 Apr; 11(2):60-1. PubMed ID: 806089
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Clinical intimations of amine balance and permission.
    Prange AJ; Lipton MA; Wilson IC
    Psychopharmacol Bull; 1974 Jul; 10(3):53-5. PubMed ID: 4419335
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.